Found 40 matching trials
The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma PHASE2 A Phase II Study Evaluating the Efficacy and Safety of LM-302 in Combinatio...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
ITIL-168 in Advanced Solid Tumors PHASE1 DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Show More Location
Multiple Locations
Learn More & Join Trial
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma PHASE2 Purpose of the Study:
This clinical study investigates whether a shorter o...
Show More Location
Amsterdam University Medical Center
Learn More & Join Trial
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer PHASE2 Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Show More Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Learn More & Join Trial
Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis N/A This multicenter, retrospective observational study aims to identify clinic...
Show More Location
Ankara Etlik City Hospital
Learn More & Join Trial
QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management N/A An increasing number of cancer patients are eligible to receive immunothera...
Show More Location
Medical Clinical Research Platform, Cancer Institute of the Hospices Civils de Lyon
Learn More & Join Trial
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. N/A Novel treatment modalities like targeted therapies and Immune checkpoint in...
Show More Location
European Institute of oncology
Learn More & Join Trial
Window of Opportunity in Preserving Laryngeal Function Trial PHASE2 This trial will study the safety and tolerability and disease survival rate...
Show More Location
UPMC Hillman Cancer
Learn More & Join Trial
Microbiome Immunotherapy Toxicity and Response Evaluation N/A This is a observational study to investigate how the microbiome correlates ...
Show More Location
Royal United Hospitals Bath NHS Foundation Trust
Learn More & Join Trial
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma PHASE2 This is a single-arm, multicenter, prospective, open-label phase II clinica...
Show More Location
Fifth Affilliated Hospital of Sun Yat-sen University
Learn More & Join Trial